Analysts See $-0.17 EPS for Fennec Pharmaceuticals Inc. (FRX); Solar Capital Ltd. (SLRC) Had 7 Bullish Analysts

April 17, 2018 - By Nellie Frank

Fennec Pharmaceuticals Inc. (TSE:FRX) Logo

Analysts expect Fennec Pharmaceuticals Inc. (TSE:FRX) to report $-0.17 EPS on May, 11.They anticipate $0.09 EPS change or 112.50% from last quarter’s $-0.08 EPS. After having $-0.19 EPS previously, Fennec Pharmaceuticals Inc.’s analysts see -10.53% EPS growth. The stock decreased 1.92% or $0.33 during the last trading session, reaching $16.86. About 1,290 shares traded. Fennec Pharmaceuticals Inc. (TSE:FRX) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 8 analysts covering Solar Capital (NASDAQ:SLRC), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Solar Capital had 16 analyst reports since August 6, 2015 according to SRatingsIntel. On Wednesday, September 30 the stock rating was initiated by DA Davidson with “Buy”. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Wednesday, August 2. The firm has “Market Outperform” rating given on Tuesday, January 16 by JMP Securities. Ladenburg Thalmann downgraded Solar Capital Ltd. (NASDAQ:SLRC) on Friday, February 24 to “Neutral” rating. The firm has “Buy” rating by Ladenburg Thalmann given on Monday, November 6. The rating was maintained by National Securities with “Buy” on Wednesday, August 5. The firm has “Buy” rating given on Friday, January 12 by Keefe Bruyette & Woods. The stock of Solar Capital Ltd. (NASDAQ:SLRC) has “Buy” rating given on Thursday, August 4 by Deutsche Bank. The firm has “Buy” rating by Deutsche Bank given on Thursday, February 25. The stock of Solar Capital Ltd. (NASDAQ:SLRC) has “Hold” rating given on Sunday, July 23 by Keefe Bruyette & Woods. See Solar Capital Ltd. (NASDAQ:SLRC) latest ratings:

16/01/2018 Broker: JMP Securities Old Rating: Market Perform New Rating: Market Outperform Upgrade
12/01/2018 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $23.0 Upgrade
12/01/2018 Broker: Wood Old Rating: Market Perform New Rating: Outperform Upgrade
06/11/2017 Broker: Ladenburg Thalmann Old Rating: Neutral New Rating: Buy Upgrade
22/10/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $23.0 Maintain

It closed at $20.5 lastly. It is down 7.76% since April 17, 2017 and is downtrending. It has underperformed by 19.31% the S&P500.

Solar Capital Ltd. is a business development firm specializing in secured debt , subordinated (unsecured) debt, minority equity, and strategic income-oriented control equity investments in leveraged middle market companies. The company has market cap of $866.35 million. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate sctivities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non precious metals; gas and oil; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It has a 12.21 P/E ratio. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools.

Solar Capital Ltd. (NASDAQ:SLRC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>